STOCKUPSIDE.IO
Analyst Price Target Intelligence
← Full Rankings
← Back to rankings
Ranked #3866 by analyst upside · 2026-08-12
MD
Pediatrix Medical Group, Inc.
Healthcare · Market Cap $2B · P/E 12.5x
ANALYST PRICE TARGET
+0.1%
implied upside to consensus target
Current Price $26.14
Consensus Target $26.17
Bull Target $28.0
Bear Target $21.0
Analysts Covering 6
ANALYST CONSENSUS - HOLD
Strong Buy
0
Buy
2
Hold
4
Sell
0
52-Week Low $14.19
52-Week High $27.94
YTD Return +22.8%
FUNDAMENTALS
Market Cap $2B
P/E Ratio (TTM) 12.5x
Forward P/E 10.7x
EPS (TTM) $2.09
PEG Ratio 0.24
Dividend Yield N/A
Revenue (TTM) $2.0B
Profit Margin 9.0%
52-WEEK RANGE
52-Week Low $14.19
52-Week High $27.94
Current Price $26.14
Bear Target $21.0
Bull Target $28.0
● Now $26.14 ● Target $26.17
TRADING DATA
Avg Volume 817K
YTD Return +22.8%
Analyst Count 6
Consensus Hold
Upside to Target +0.1%
Last Updated 2026-08-12

ANALYST SUMMARY

Pediatrix Medical Group, Inc. (MD) is currently trading at $26.14 with a Wall Street consensus price target of $26.17, implying potential upside of 0.1% over the next 12 months. 6 analysts currently cover MD, with a consensus rating of Hold - 33% of analysts rate the stock a Buy or Strong Buy. The most bullish analyst has a price target of $28.0, while the most cautious has a target of $21.0.

MD operates in the Healthcare sector with a market capitalisation of $2B. The stock is up 22.8% year-to-date and is currently trading near the upper end of its 52-week range of $14.19 – $27.94.

SIMILAR STOCKS

Other Healthcare stocks with comparable size and valuation.

RECENT ANALYST CALLS

Upgrade/downgrade history for MD, with each firm's 90-day track record across all stocks we track. See full firm rankings →

UBS - Reiterated
Neutral → Neutral 2026-05-12 33% win rate (6 calls)
Truist Securities - Reiterated
Hold → Hold 2026-04-13 Building track record
UBS - Reiterated
Neutral → Neutral 2026-02-24 33% win rate (6 calls)
Truist Securities - Reiterated
Hold → Hold 2026-02-20 Building track record
Truist Securities - Reiterated
Hold → Hold 2025-11-10 Building track record
UBS - Reiterated
Neutral → Neutral 2025-11-05 33% win rate (6 calls)
Leerink Partners - Reiterated
Market Perform → Market Perform 2025-09-05 29% win rate (7 calls)
UBS - Reiterated
Neutral → Neutral 2025-08-14 33% win rate (6 calls)
HISTORICAL SNAPSHOT

Point-in-time data from StockUpside's daily snapshots. Tracks price, analyst target, upside %, consensus, and analyst count.

Loading…
ANALYST CONVICTION SCORE
42
out of 100
Coverage depth
15/30
Consensus clarity
25/30
Vote unanimity
0/25
Rating stability
2/15

Measures analyst agreement, not fundamental quality. A high score means analysts broadly agree on this call - not that the stock will go up.

See 4,000+ stocks ranked by analyst upside

StockUpside.io tracks analyst consensus price targets across thousands of US-listed stocks, updated every day. The full ranked list is available with a Pro subscription.

View Full Rankings →